4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-25-000146
EVP, Chief Reg. & Quality Off. sold 3,242 shares at $499.99 ($1,620,968)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Tatsis Ourania · EVP, Chief Reg. & Quality Off.
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-10 | Sale : show line 1 in the form 10b5-1 | −3,242 | $499.99 | $1,620,968 | 51,239 | D |
| Open-market sales · 3,242 sh · avg $499.99 · $1,620,968 | ||||||
Loading xslF345X05/wk-form4_1741810227.xml…